1. Home
  2. OSK vs AXSM Comparison

OSK vs AXSM Comparison

Compare OSK & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oshkosh Corporation

OSK

Oshkosh Corporation

BUY

Current Price

$152.90

Market Cap

9.8B

ML Signal

BUY

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$183.12

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSK
AXSM
Founded
1917
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
8.6B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
OSK
AXSM
Price
$152.90
$183.12
Analyst Decision
Buy
Strong Buy
Analyst Count
14
17
Target Price
$166.79
$211.12
AVG Volume (30 Days)
533.7K
503.9K
Earning Date
05-08-2026
05-04-2026
Dividend Yield
1.54%
N/A
EPS Growth
N/A
38.56
EPS
1.14
N/A
Revenue
$7,705,500,000.00
N/A
Revenue This Year
$5.94
$57.24
Revenue Next Year
$7.19
$55.88
P/E Ratio
$129.91
N/A
Revenue Growth
12.83
N/A
52 Week Low
$82.14
$96.09
52 Week High
$180.49
$191.50

Technical Indicators

Market Signals
Indicator
OSK
AXSM
Relative Strength Index (RSI) 54.21 60.51
Support Level $137.24 $178.00
Resistance Level $158.57 $184.40
Average True Range (ATR) 5.57 5.55
MACD 0.77 0.93
Stochastic Oscillator 74.66 72.42

Price Performance

Historical Comparison
OSK
AXSM

About OSK Oshkosh Corporation

Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (45% of revenue), Vocational (35%), and Transport (20%) on 2025 revenue of $10.4 billion.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: